IL154776A0 - Method for the preparation of 21-hydroxy-6, 19-oxidoprogesterone and derivatives thereof - Google Patents

Method for the preparation of 21-hydroxy-6, 19-oxidoprogesterone and derivatives thereof

Info

Publication number: IL154776A0
Authority: IL; Israel
Prior art keywords: oxidoprogesterone; hydroxy; derivatives; preparation; phosphorlated
Prior art date: 2000-09-18

Application number

IL15477601A

Other languages

English (en)

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-18

Filing date

2001-09-17

Publication date

2003-10-31

2001-09-17 Application filed by Applied Research Systems filed Critical Applied Research Systems

2003-10-31 Publication of IL154776A0 publication Critical patent/IL154776A0/xx

Links

FIHWBGCIKMXLBI-NXMWLWCLSA-N (8s,9s,10s,13s,14s,17s)-17-acetyl-10-(hydroxymethyl)-13-methyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound C1CC2=CC(=O)CC[C@]2(CO)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 FIHWBGCIKMXLBI-NXMWLWCLSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IL15477601A 2000-09-18 2001-09-17 Method for the preparation of 21-hydroxy-6, 19-oxidoprogesterone and derivatives thereof IL154776A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00119494		2000-09-18
PCT/EP2001/010734 WO2002022646A2 (en)	2000-09-18	2001-09-17	Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)

Publications (1)

Publication Number	Publication Date
IL154776A0 true IL154776A0 (en)	2003-10-31

Family

ID=8169774

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL15477601A IL154776A0 (en)	2000-09-18	2001-09-17	Method for the preparation of 21-hydroxy-6, 19-oxidoprogesterone and derivatives thereof
IL154776A IL154776A (en)	2000-09-18	2003-03-05	Method for the preparation of 12-hydroxy - 6, 19 - oxidoprogesterone and derivatives thereof

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL154776A IL154776A (en)	2000-09-18	2003-03-05	Method for the preparation of 12-hydroxy - 6, 19 - oxidoprogesterone and derivatives thereof

Country Status (13)

Country	Link
US (4)	US7071328B2 (de)
EP (1)	EP1325022B1 (de)
JP (1)	JP2004509131A (de)
AT (1)	ATE344273T1 (de)
AU (2)	AU1817902A (de)
CA (1)	CA2419960A1 (de)
DE (1)	DE60124289T2 (de)
DK (1)	DK1325022T3 (de)
ES (1)	ES2271090T3 (de)
IL (2)	IL154776A0 (de)
PT (1)	PT1325022E (de)
SI (1)	SI1325022T1 (de)
WO (1)	WO2002022646A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7071328B2 (en) *	2000-09-18	2006-07-04	Applied Research System Ars Holding N.V.	Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21 oh-6op)
DK1330468T3 (da) *	2000-09-18	2007-11-05	Serono Lab	Svovlanaloger af 21 hydroxy-6,19-oxido-progesteron (21OH 6OP) til behandling af overskud af glucocorticoider
ES2424970T3 (es)	2006-03-10	2013-10-10	Ipsen Pharma	Uso de un agonista de la grelina para mejorar los efectos catabólicos del tratamiento con glucocorticoides
EP1862468A1 (de) *	2006-06-02	2007-12-05	Bayer Schering Pharma Aktiengesellschaft	Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on
DE102009034366A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de)	2009-07-21	2011-02-10	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de)	2009-07-21	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007719A1 (de)	2010-02-10	2011-08-11	Bayer Schering Pharma Aktiengesellschaft, 13353	Progesteronrezeptorantagonisten
DE102010007722A1 (de)	2010-02-10	2011-08-11	Bayer Schering Pharma Aktiengesellschaft, 13353	Progesteronrezeptorantagonisten
IN2015DN03055A (de)	2012-10-09	2015-10-02	Avery Dennison Corp
AU2019351004B2 (en) *	2018-09-28	2023-09-14	The Regents Of The University Of Michigan	Halogenated cholesterol analogues and methods of making and using same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3036068A (en) *	1960-01-06	1962-05-22	Syntex Sa	C-6, 19-steroidal lactones
LU77457A1 (de) *	1977-05-31	1979-01-19
US4814333A (en) *	1987-07-28	1989-03-21	The Trustees Of Dartmouth College	Method for treatment of hypercortisolemic, depressed patients
GB9606016D0 (en) *	1996-03-22	1996-05-22	Smithkline Beecham Plc	Novel use
EP0903146A1 (de)	1997-09-23	1999-03-24	Applied Research Systems ARS Holdings N.V.	21-Hydroy-6,19-oxidoprogesterone (21-0H-60P) als ANitoglucocortikoid
AU747956B2 (en) *	1997-10-06	2002-05-30	Board Of Trustees Of The Leland Stanford Junior University	Methods for treating psychosis associated with glucocorticoid related dysfunction
DK1330468T3 (da) *	2000-09-18	2007-11-05	Serono Lab	Svovlanaloger af 21 hydroxy-6,19-oxido-progesteron (21OH 6OP) til behandling af overskud af glucocorticoider
US7071328B2 (en) *	2000-09-18	2006-07-04	Applied Research System Ars Holding N.V.	Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21 oh-6op)

2001
- 2001-09-17 US US10/380,167 patent/US7071328B2/en not_active Expired - Fee Related
- 2001-09-17 JP JP2002526897A patent/JP2004509131A/ja active Pending
- 2001-09-17 AU AU1817902A patent/AU1817902A/xx active Pending
- 2001-09-17 CA CA002419960A patent/CA2419960A1/en not_active Abandoned
- 2001-09-17 WO PCT/EP2001/010734 patent/WO2002022646A2/en not_active Ceased
- 2001-09-17 ES ES01984642T patent/ES2271090T3/es not_active Expired - Lifetime
- 2001-09-17 IL IL15477601A patent/IL154776A0/xx active IP Right Grant
- 2001-09-17 DK DK01984642T patent/DK1325022T3/da active
- 2001-09-17 PT PT01984642T patent/PT1325022E/pt unknown
- 2001-09-17 SI SI200130675T patent/SI1325022T1/sl unknown
- 2001-09-17 AU AU2002218179A patent/AU2002218179B2/en not_active Ceased
- 2001-09-17 EP EP01984642A patent/EP1325022B1/de not_active Expired - Lifetime
- 2001-09-17 AT AT01984642T patent/ATE344273T1/de not_active IP Right Cessation
- 2001-09-17 DE DE60124289T patent/DE60124289T2/de not_active Expired - Fee Related
2003
- 2003-03-05 IL IL154776A patent/IL154776A/en not_active IP Right Cessation
2005
- 2005-06-01 US US11/141,029 patent/US20050277769A1/en not_active Abandoned
2007
- 2007-04-12 US US11/734,628 patent/US20070249826A1/en not_active Abandoned
2009
- 2009-02-09 US US12/367,859 patent/US20090216008A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2002022646A3 (en)	2002-06-06
AU1817902A (en)	2002-03-26
US7071328B2 (en)	2006-07-04
CA2419960A1 (en)	2002-03-21
ES2271090T3 (es)	2007-04-16
WO2002022646A2 (en)	2002-03-21
WO2002022646A9 (en)	2002-09-19
PT1325022E (pt)	2006-12-29
DE60124289D1 (de)	2006-12-14
US20050277769A1 (en)	2005-12-15
SI1325022T1 (sl)	2007-04-30
IL154776A (en)	2007-07-04
US20040092733A1 (en)	2004-05-13
US20090216008A1 (en)	2009-08-27
ATE344273T1 (de)	2006-11-15
EP1325022B1 (de)	2006-11-02
US20070249826A1 (en)	2007-10-25
DE60124289T2 (de)	2007-09-06
EP1325022A2 (de)	2003-07-09
AU2002218179B2 (en)	2006-11-16
JP2004509131A (ja)	2004-03-25
DK1325022T3 (da)	2007-02-19

Similar Documents

Publication	Publication Date	Title
MXPA02008801A (es)	2003-07-07	Derivados de indol, proceso para la preparacion de los mismos y su uso.
AU2001236148A1 (en)	2001-08-27	Polyorganosilsesquioxane and process for preparing the same
IL147803A0 (en)	2002-08-14	28-epirapalogs
AU2002218140A1 (en)	2002-04-29	Beam-shaping method
EG23254A (en)	2004-09-29	Device and method for the generation of electricalenergy.
AU2001229113A1 (en)	2001-07-31	Reflector, method for the production of reflector, and internal-lighting displaydevice
MXPA03008630A (es)	2003-12-08	Derivados de arilisoxazolinas, procedimientos para su preparacion y su utilizacion como agentes plaguicidas.
ZA200300743B (en)	2004-02-10	DDS compound and process for the preparation thereof.
AU2002356533A1 (en)	2003-04-14	Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis
PL346463A1 (en)	2001-09-24	Method of obtaining derivatives of resorcinol, method of obtaining novel derivatives of 2-oxazabicyclo[2.2.2.]-octan-5-one, method of obtaining novel derivatives of 1,3-cyclohezandione, method of obtaining novel derivatives of 2-cyclohexanone, novel derivatives of 2-oxazabicyclo[2.2.2.]-octan-5-one, novel derivatives of 1,3-cyclohexanodione, and novel derivatives of 2-cyclohexenonea
AU1817902A (en)	2002-03-26	Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
AU3425700A (en)	2000-09-21	Non-ribosomal peptide synthetases, method for producing same and the use thereof
ZA200110388B (en)	2002-06-20	Method of producing nitroguanidine- and nitroenamine derivatives.
AU2001287668A1 (en)	2002-03-22	Method for the sterilisation of objects
MXPA03002738A (es)	2004-01-26	Derivados de 6-metil-tramadol o-sustituidos.
AU4472801A (en)	2001-10-23	Inactivated japanese B encephalitis vaccine and process for producing the same
AU2000254308A1 (en)	2001-11-26	Pyrazolopyrimidinone derivatives, process for their preparation and their use
AU2001295579A1 (en)	2002-04-02	Pants and method for the production thereof
AU2002227966A1 (en)	2002-08-22	Coniosetin and derivatives thereof, method for producing the same and use thereof
IL156162A0 (en)	2003-12-23	Coniosetin and derivatives thereof, method for producing the same and use thereof.
ZA200210361B (en)	2003-11-13	Method of administering bishosphonates.
AU2000261768A1 (en)	2002-02-18	An improved process for the preparation of docetaxel
IL138117A0 (en)	2001-10-31	5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them
MXPA03004632A (es)	2003-09-05	Klainetina y sus derivados, metodo para su produccion y su uso.
MXPA03007550A (es)	2003-12-04	Derivados coloporosidos, proceso para su preparacion y su uso.

Legal Events

Date	Code	Title	Description
2007-12-03	FF	Patent granted
2008-01-22	KB	Patent renewed